Clinical Outcomes and Considerations in Outpatients with COVID-19 Receiving Remdesivir Therapy

This retrospective study evaluated 514 Covid-19 patients treated with remdesivir at an outpatient department. Early administration of remdesivir led to better outcomes, particularly for those with lower blood saturation levels, while corticosteroids showed limited benefits. Patients with over 50% lung involvement experienced higher disease progression despite treatment. Side effects from remdesivir were rare, with only a small percentage experiencing increased liver enzymes, facial redness, tremors, or allergies. Common symptoms after treatment included hair loss, fatigue, and body pain. Outpatient treatment was generally preferred over hospitalization, and BMI did not significantly affect hospitalization rates. Overall, remdesivir was effective with a low incidence of side effects.